Kantonsspital St.Gallen

Absorb first registry

Daniel Weilenmann, Rene Vollenbroich & Michaela Gemperle

abstract A global post-market registry of patients with de novo lesions in previously untreated vessels treated with Absorb BVS per IFU (on-label use)
type of project clinical studies
status completed
start of project 2013
end of project 2015
study design Beobachtungsstudie
responsible person Dr.Daniel Weilenmann